لخّصلي

Pathophysiology of Sickling: The underlying mechanism of sickle cell disease is the presence of hemoglobin S. Under conditions where oxygen levels are low, HbS molecules exhibit a strong tendency to aggregate and polymerize.This polymerization process involves the formation of rigid, insoluble fibers within the red blood cells.

Pathophysiology of Sickling:
The underlying mechanism of sickle cell disease is the presence of hemoglobin S. Under conditions where oxygen levels are low, HbS molecules exhibit a strong tendency to aggregate and polymerize. This polymerization process involves the formation of rigid, insoluble fibers within the red blood cells. The presence of these rigid fibers causes the normally flexible, biconcave disc-shaped red blood cells to distort and adopt the characteristic crescent or "sickle" shape that gives the disease its name.  
These abnormally shaped red blood cells lose their flexibility and cannot navigate the narrow capillaries of the circulatory system as easily as normal red blood cells. Their rigidity and increased stickiness can lead to the obstruction of blood flow within these small vessels, a phenomenon known as vaso-occlusion. This blockage impairs the delivery of oxygen to tissues and organs throughout the body, resulting in ischemia (a deficiency of oxygen supply), the onset of pain, and, over time, potential damage to various organs.  
Furthermore, the sickled red blood cells are fragile and have a significantly reduced lifespan, typically surviving for only 10 to 20 days compared to the normal 90 to 120 days. This premature destruction of red blood cells leads to chronic hemolytic anemia, a characteristic feature of SCD.  
Several factors can influence the process of red blood cell sickling. These include conditions of low oxygen levels in the blood, a high concentration of HbS within the red blood cells, dehydration, an increase in the acidity of the blood (acidosis), the presence of illness or infection, physical or emotional stress, and exposure to extreme temperatures or high altitudes.  
The polymerization of HbS under deoxygenated conditions is the central event in the pathophysiology of SCD. This process initiates a cascade of detrimental effects, leading to vaso-occlusion, hemolysis, and the diverse range of clinical manifestations associated with the disease. A thorough understanding of the delicate balance of factors that influence this polymerization is essential for the development of effective therapeutic interventions aimed at disrupting HbS polymerization or improving the flexibility of red blood cells.